Open access
Sep 2026
Long-term outcomes of high-dose hyperfractionated thoracic radiotherapy for limited-stage small-cell lung cancer.
High-dose hyperfractionated radiotherapy may be a feasible dose-escalated option for patients with LS-SCLC, with acceptable toxicity, with published data on the long-term outcomes of this specific regimen.
Yasuhito Hagiwara, Yuuki Kuroda, Kenji Takai et al.
· Journal of Radiation Researc... · 0 citations